|
|
|
|
| LEADER |
02865nam a2200481 4500 |
| 001 |
ocn897474051 |
| 003 |
OCoLC |
| 005 |
20180501122023.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
141204t20142014ne a ob 001 0 eng d |
| 040 |
|
|
|a BUF
|b eng
|e rda
|c BUF
|d UIU
|d YDXCP
|d UKMGB
|d CUS
|d VVL
|d ESU
|d TFH
|d OCLCO
|d BUF
|d GrThAP
|
| 015 |
|
|
|a GBB4B8603
|2 bnb
|
| 016 |
7 |
|
|a 016911997
|2 Uk
|
| 020 |
|
|
|a 9780123979186 (hbk.)
|
| 020 |
|
|
|a 0123979188 (hbk.)
|
| 035 |
|
|
|a (OCoLC)897474051
|
| 050 |
1 |
4 |
|a QP606.P76
|b P76 2014
|
| 050 |
|
4 |
|a QP601
|b .M49 v.548
|
| 060 |
0 |
0 |
|a W1 ME9615K
|b v.548 2014
|
| 060 |
1 |
0 |
|a QU 143
|
| 082 |
0 |
4 |
|a 572.792
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Protein kinase inhibitors in research and medicine.
|n Volume 548 /
|c edited by Kevan M. Shokat.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier Academic Press,
|c 2014.
|
| 264 |
|
4 |
|c Ã2014
|
| 300 |
|
|
|a 1 online resource (xii, 241 pages, 42 unnumbered pages of plates) :
|b illustrations (chiefly color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in enzymology,
|x 0076-6879 ;
|v volume 548
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 505 |
0 |
0 |
|t Catalytic mechanisms and regulation of protein kinases /
|r Zhihong Wang and Philip A. Cole --
|t A structural atlas of kinases inhibited by clinically approved drugs /
|r Qi Wang, Julie A. Zorn, and John Kuriyan --
|t Fragment-based approaches to the discovery of kinase inhibitors /
|r Paul N. Mortenson, Valerio Berdini, and Marc O'Reilly --
|t Targeting protein kinases with selective and semipromiscuous covalent inhibitors /
|r Rand M. Miller and Jack Taunton --
|t The resistance tetrad : amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles /
|r Fiona P. Bailey, Veselin I. Andreev, and Patrick A. Eyers --
|t FLiK : a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformations /
|r Jeffrey R. Simar and Daniel Rauh --
|t Discovery of allosteric Bcr-Abl inhibitors from phenotypic screen to clinical candidate /
|r Nathanael S. Gray and Doriano Fabbro --
|t The logic and design of analog-sensitive kinases and their small molecule inhibitors /
|r Michael S. Lopez, Joseph I. Kliegman, and Kevan M. Shokat.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Protein kinases
|x Inhibitors.
|
| 650 |
|
2 |
|a Protein Kinases.
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
7 |
|a Electronic books.
|2 lcgft
|
| 700 |
1 |
|
|a Shokat, Kevan,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Protein kinase inhibitors in research and medicine
|z 9780123979186
|w (OCoLC)894270384
|
| 830 |
|
0 |
|a Methods in enzymology ;
|v v. 548.
|x 0076-6879
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00766879/548
|z Full Text via HEAL-Link
|
